221 related articles for article (PubMed ID: 29784508)
1. IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model.
Martin Jensen M; Jia W; Schults AJ; Ye X; Prestwich GD; Oottamasathien S
Cytokine; 2018 Oct; 110():420-427. PubMed ID: 29784508
[TBL] [Abstract][Full Text] [Related]
2. Physiological relevance of LL-37 induced bladder inflammation and mast cells.
Oottamasathien S; Jia W; Roundy LM; Zhang J; Wang L; Ye X; Hill AC; Savage J; Lee WY; Hannon AM; Milner S; Prestwich GD
J Urol; 2013 Oct; 190(4 Suppl):1596-1602. PubMed ID: 23313203
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
Wang X; Liu W; O'Donnell M; Lutgendorf S; Bradley C; Schrepf A; Liu L; Kreder K; Luo Y
PLoS One; 2016; 11(12):e0168772. PubMed ID: 28002455
[TBL] [Abstract][Full Text] [Related]
4. Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model.
Bicer F; Altuntas CZ; Izgi K; Ozer A; Kavran M; Tuohy VK; Daneshgari F
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F103-13. PubMed ID: 25209862
[TBL] [Abstract][Full Text] [Related]
5. Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.
Jia W; Schults AJ; Jensen MM; Ye X; Alt JA; Prestwich GD; Oottamasathien S
Am J Clin Exp Urol; 2017; 5(2):10-17. PubMed ID: 29034266
[TBL] [Abstract][Full Text] [Related]
6. Digital quantitative analysis of mast cell infiltration in interstitial cystitis.
Akiyama Y; Maeda D; Morikawa T; Niimi A; Nomiya A; Yamada Y; Igawa Y; Goto A; Fukayama M; Homma Y
Neurourol Urodyn; 2018 Feb; 37(2):650-657. PubMed ID: 29065222
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis.
Rudick CN; Schaeffer AJ; Klumpp DJ
BMC Urol; 2009 Nov; 9():16. PubMed ID: 19909543
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
Liu BK; Jin XW; Lu HZ; Zhang X; Zhao ZH; Shao Y
Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
[TBL] [Abstract][Full Text] [Related]
9. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
Cui X; Jing X; Lutgendorf SK; Bradley CS; Schrepf A; Erickson BA; Magnotta VA; Ness TJ; Kreder KJ; O'Donnell MA; Luo Y
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F90-F98. PubMed ID: 31091120
[TBL] [Abstract][Full Text] [Related]
10. The study on the function and cell source of interleukin-6 in interstitial cystitis/bladder painful syndrome rat model.
Zheng Z; Zhang J; Zhang C; Li W; Ma K; Huang H; Li K; Yao Y
Immun Inflamm Dis; 2021 Dec; 9(4):1520-1528. PubMed ID: 34407316
[TBL] [Abstract][Full Text] [Related]
11. Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.
Corcoran AT; Yoshimura N; Tyagi V; Jacobs B; Leng W; Tyagi P
World J Urol; 2013 Feb; 31(1):241-6. PubMed ID: 22441309
[TBL] [Abstract][Full Text] [Related]
12. Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan.
Lee WY; Savage JR; Zhang J; Jia W; Oottamasathien S; Prestwich GD
PLoS One; 2013; 8(10):e77854. PubMed ID: 24204996
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of interstitial cystitis/bladder pain syndrome based on gene expression.
Karamali M; Shafabakhsh R; Ghanbari Z; Eftekhar T; Asemi Z
J Cell Physiol; 2019 Aug; 234(8):12301-12308. PubMed ID: 30609029
[TBL] [Abstract][Full Text] [Related]
14. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome.
Shie JH; Kuo HC
BJU Int; 2011 Jul; 108(2 Pt 2):E136-41. PubMed ID: 21166752
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of bladder mast cell growth factor receptor (c-kit) in interstitial cystitis.
Pang X; Sant G; Theoharides TC
Urology; 1998 Jun; 51(6):939-44. PubMed ID: 9609630
[TBL] [Abstract][Full Text] [Related]
16. Identification of key pathways and mRNAs in interstitial cystitis/bladder pain syndrome treatment with quercetin through bioinformatics analysis of mRNA-sequence data.
Wang G; Li P; Su SW; Xu R; Huang ZY; Yang TX; Li JM
Aging (Albany NY); 2024 Mar; 16(7):5949-5966. PubMed ID: 38526326
[TBL] [Abstract][Full Text] [Related]
17. A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.
Keay S; Leitzell S; Ochrzcin A; Clements G; Zhan M; Johnson D
BMC Urol; 2012 Jun; 12():17. PubMed ID: 22682521
[TBL] [Abstract][Full Text] [Related]
18. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
Kochiashvili G; Kochiashvili D
Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264
[TBL] [Abstract][Full Text] [Related]
19. Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice.
Izgi K; Altuntas CZ; Bicer F; Ozer A; Sakalar C; Li X; Tuohy VK; Daneshgari F
PLoS One; 2013; 8(8):e72067. PubMed ID: 23977210
[TBL] [Abstract][Full Text] [Related]
20. The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment.
Singh UP; Singh NP; Guan H; Hegde VL; Price RL; Taub DD; Mishra MK; Nagarkatti M; Nagarkatti PS
PLoS One; 2013; 8(11):e79751. PubMed ID: 24278169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
